Similar MMP-14 targeting has been demonstrated to improve cytoreductive surgery in childhood neuroblastoma by the creation of a FRET nanoprobe conjugated to MMP-14 peptide, in which cleavage of the peptide results in tumor illumination. Here, MMP14 is linked to neuroblastoma.